No notable differences were found in CRC survival in terms of patient age, sex, pT stage, colon or rectal cancer types, and patients with low or high levels of HLA-G:ILT-2, and HLA-G:PD-L1 expression (Table 2 and Figure 3). This evidence concerns the gene HLA-G and rectal cancer.